Company Description
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.
It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration.
It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online.
The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau.
USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
| Country | United States |
| Founded | 1992 |
| IPO Date | Jul 25, 1996 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 1,700 |
| CEO | Jim Brown |
Contact Details
Address: 3838 West Parkway Boulevard Salt Lake City, Utah 84120 United States | |
| Phone | 801 954 7100 |
| Website | usana.com |
Stock Details
| Ticker Symbol | USNA |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000896264 |
| CUSIP Number | 90328M107 |
| ISIN Number | US90328M1071 |
| Employer ID | 87-0500306 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Jim Brown | Chief Executive Officer and President |
| G. Douglas Hekking | Chief Financial Officer |
| Walter Noot | Chief Operating Officer |
| P. Joshua Foukas J.D. | Chief Legal Officer, General Counsel and Corporate Secretary |
| Brent L. Neidig | Chief Commercial Officer |
| Dr. Myron W. Wentz Ph.D. | Founder and Chairman Emeritus |
| Dr. John Cuomo | Executive Director of Product Development and Technology |
| Peter Benedict | Chief Information Officer |
| Patrique Richards | Executive Director of Investor Relations and Business Development |
| David Mulham | Chief Sales Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 22, 2025 | 8-K | Current Report |
| Apr 16, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 9, 2025 | ARS | Filing |
| Apr 9, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 4, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 12, 2025 | 144 | Filing |
| Mar 12, 2025 | 144 | Filing |
| Mar 12, 2025 | 10-K | Annual Report |
| Mar 10, 2025 | 144 | Filing |
| Mar 7, 2025 | 144 | Filing |